In addition to promoting angiogenesis in GC through MCP-1, TAMs may also directly promote angiogenesis and lymphangiogenesis of GC possibly by enhancing the expression of VEGF and VEGF-C (65). This evidence concerns the gene VEGFC and gastric cancer.